|
 |
|
|||||||
|
|||||||||
© 2005 by the American Diabetes Association, Inc.
Clinical Care/Education/Nutrition |
A Two-Center Randomized Controlled Feasibility Trial of Insulin Pump Therapy in Young Children With Diabetes
1 Divisions of Pediatric Endocrinology and Diabetes, Stanford University, Stanford, California
2 University of California, San Francisco, California
Address correspondence and reprint requests to Darrell M. Wilson, MD, Professor and Chief Pediatric Endocrinology and Diabetes, Stanford University, S-302 Medical Center, Stanford, CA 94305-5208. E-mail: dwilson{at}stanford.edu
OBJECTIVE—Our goals were to determine if continuous subcutaneous insulin infusion (CSII), compared with those continuing multiple daily injections (MDIs), can be safely used in young children, if those on CSII will have superior glycemic control, if subjects using CSII will have less hypoglycemia for their level of control, and if families using CSII will report an improved quality of life.
RESEARCH DESIGN AND METHODS—We conducted a randomized 1-year feasibility trial comparing CSII with continuing MDIs in preschool children with a history of type 1 diabetes for at least 6 months’ duration. Prospective outcomes included measures of overall glycemic control (HbA1c and continuous glucose monitoring system), the incidence of severe hypoglycemia and diabetic ketoacidosis, the percent of glucose values below 3.9 mmol/l, and the parents’ report of quality of life.
RESULTS—The 19 subjects’ ages ranged from 1.7 to 6.1 (mean 3.6) years, duration of diabetes ranged from 0.6 to 2.6 (mean 1.4) years, and baseline HbA1c ranged from 6.7 to 9.6% (mean 7.9%). Seven subjects were male. Nine subjects were randomized to start CSII and 10 to continue on MDI. All baseline characteristics were well balanced. Overall metabolic control, diabetes quality of life, and the incidence of hypoglycemia were similar in the two groups. No subject had diabetic ketoacidosis, while one subject in each group had an episode of severe hypoglycemia. No CSII subject discontinued using the pump during or after the study.
CONCLUSIONS—CSII can be a safe and effective method to deliver insulin in young children.
Abbreviations: CGMS, continuous glucose monitoring system • CSII, continuous subcutaneous insulin infusion • DQOL, Diabetes Quality of Life • MDI, multiple daily injection
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J. U. Cope, A. E. Morrison, and J. Samuels-Reid Adolescent Use of Insulin and Patient-Controlled Analgesia Pump Technology: A 10-Year Food and Drug Administration Retrospective Study of Adverse Events Pediatrics, May 1, 2008; 121(5): e1133 - e1138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shalitin and M. Phillip Hypoglycemia in Type 1 Diabetes: A still unresolved problem in the era of insulin analogs and pump therapy Diabetes Care, February 1, 2008; 31(Supplement_2): S121 - S124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Pickup and E. Renard Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes Diabetes Care, February 1, 2008; 31(Supplement_2): S140 - S145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Phillip, T. Battelino, H. Rodriguez, T. Danne, F. Kaufman, and for the Consensus forum participants Use of Insulin Pump Therapy in the Pediatric Age-Group: Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care, June 1, 2007; 30(6): 1653 - 1662. [Full Text] [PDF]
|
|
|
|
|
|
P.-M. Holterhus, R. Odendahl, S. Oesingmann, R. Lepler, V. Wagner, O. Hiort, R. Holl, and the German/Austrian DPV Initiative and the German Classification of Distinct Baseline Insulin Infusion Patterns in Children and Adolescents With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy Diabetes Care, March 1, 2007; 30(3): 568 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Wood, E. C. Moreland, L. K. Volkening, B. M. Svoren, D. A. Butler, and L. M.B. Laffel Durability of insulin pump use in pediatric patients with type 1 diabetes. Diabetes Care, November 1, 2006; 29(11): 2355 - 2360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Eugster, G. Francis, and and the Lawson-Wilkins Drug and Therapeutics Commi Position Statement: Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes Pediatrics, October 1, 2006; 118(4): e1244 - e1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Nahata Insulin Therapy in Pediatric Patients with Type I Diabetes: Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections. Clinical Pediatrics, July 1, 2006; 45(6): 503 - 508. [Abstract] [PDF]
|
|
|
|
|
|
D. S. Schade and V. Valentine Counterpoint: Are Insulin Pumps Underutilized in Type 1 Diabetes? No. Diabetes Care, June 1, 2006; 29(6): 1453 - 1455. [Full Text] [PDF]
|
|
|
|
|
|
T. Berhe, D. Postellon, B. Wilson, and R. Stone Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study. Pediatrics, June 1, 2006; 117(6): 2132 - 2137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Varma Insulin Pump in Young Children with Diabetes AAP Grand Rounds, December 1, 2005; 14(6): 68 - 68. [Full Text] [PDF]
|
|
|
|
|
|
L. A. Fox, L. M. Buckloh, S. D. Smith, T. Wysocki, and N. Mauras A Randomized Controlled Trial of Insulin Pump Therapy in Young Children With Type 1 Diabetes Diabetes Care, June 1, 2005; 28(6): 1277 - 1281. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |